PharmaCyte Biotech, Inc. Quarterly Debt-to-equity in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PharmaCyte Biotech, Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Debt-to-equity for the quarter ending July 31, 2024 was 56.3 %, a 558% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 56.3 +47.8 +558% Jul 31, 2024
Q1 2024 62.3 +61.1 +5077% Apr 30, 2024
Q4 2023 35.7 +34.5 +2935% Jan 31, 2024
Q3 2023 18.9 +17.8 +1670% Oct 31, 2023
Q2 2023 8.56 +7.84 +1088% Jul 31, 2023
Q1 2023 1.2 +0.33 +37.9% Apr 30, 2023
Q4 2022 1.18 -0.07 -5.6% Jan 31, 2023
Q3 2022 1.07 -1.15 -51.9% Oct 31, 2022
Q2 2022 0.72 -9.76 -93.2% Jul 31, 2022
Q1 2022 0.87 -10.3 -92.2% Apr 30, 2022
Q4 2021 1.25 -11.9 -90.5% Jan 31, 2022
Q3 2021 2.22 -14.3 -86.6% Oct 31, 2021
Q2 2021 10.5 -9.77 -48.3% Jul 31, 2021
Q1 2021 11.2 -7.32 -39.5% Apr 30, 2021
Q4 2020 13.1 -3.65 -21.7% Jan 31, 2021
Q3 2020 16.5 +3.34 +25.4% Oct 31, 2020
Q2 2020 20.3 +8.31 +69.6% Jul 31, 2020
Q1 2020 18.5 +5.98 +47.7% Apr 30, 2020
Q4 2019 16.8 +5.09 +43.5% Jan 31, 2020
Q3 2019 13.2 -0.09 -0.68% Oct 31, 2019
Q2 2019 11.9 +0.08 +0.68% Jul 31, 2019
Q1 2019 12.5 +1.81 +16.9% Apr 30, 2019
Q4 2018 11.7 +2.01 +20.7% Jan 31, 2019
Q3 2018 13.3 +4.93 +59.2% Oct 31, 2018
Q2 2018 11.9 +3.63 +44.1% Jul 31, 2018
Q1 2018 10.7 +3.48 +48% Apr 30, 2018
Q4 2017 9.69 +1.81 +23% Jan 31, 2018
Q3 2017 8.32 -1.41 -14.5% Oct 31, 2017
Q2 2017 8.23 -3.59 -30.4% Jul 31, 2017
Q1 2017 7.25 -6.73 -48.2% Apr 30, 2017
Q4 2016 7.88 -8.5 -51.9% Jan 31, 2017
Q3 2016 9.73 -4.65 -32.3% Oct 31, 2016
Q2 2016 11.8 +0.01 +0.09% Jul 31, 2016
Q1 2016 14 +4.96 +55% Apr 30, 2016
Q4 2015 16.4 +11.6 +244% Jan 31, 2016
Q3 2015 14.4 +9.09 +172% Oct 31, 2015
Q2 2015 11.8 +3.13 +36.1% Jul 31, 2015
Q1 2015 9.02 -5.44 -37.6% Apr 30, 2015
Q4 2014 4.76 -63.4 -93% Jan 31, 2015
Q3 2014 5.3 -486 -98.9% Oct 31, 2014
Q2 2014 8.67 +347 Jul 31, 2014
Q1 2014 14.5 +209 Apr 30, 2014
Q4 2013 68.2 +246 Jan 31, 2014
Q3 2013 491 +660 Oct 31, 2013
Q2 2013 -339 -178 -111% Jul 31, 2013
Q1 2013 -195 -42 -27.5% Apr 30, 2013
Q4 2012 -177 -35.6 -25.1% Jan 31, 2013
Q3 2012 -169 Oct 31, 2012
Q2 2012 -160 Jul 31, 2012
Q1 2012 -153 Apr 30, 2012
Q4 2011 -142 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.